Rahul Saxena

Dr. Rahul Saxena


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2011 in Therapeutic Advances in Musculoskeletal Disease
Verified
Journal Article
Open access
IBIjen Bhattacharya
Ijen Bhattacharya
RSRahul Saxena
Rahul Saxena
VGVeena Gupta
Veena Gupta
Background: Osteoarthritis (OA) is the most common cause of chronic pain and disability in the elderly. It involves progressive destruction of articular cartilage as a consequence of various factors including augmented oxidative stress with advancing age which has not yet been controlled. It is conceivable that exogenous vitamin E supplementation ameliorates the modifiable indexes via regulation of free radical production and the consumption of antioxidant reserve. The objectives of the present study were to investigate the therapeutic effect of vitamin E supplementation in ameliorating the altered activity of antioxidant enzymes (superoxide dismutase, ceruloplasmin, glutathione peroxidase and catalase), erythrocyte malondialdehyde level (MDA, i.e. marker of lipid peroxidation) and markers of systemic inflammation (plasma C-reactive protein [CRP] and synovial fluid interleukin 6 [IL-6]) in osteoarthritic elderly. Methods: Antioxidant enzymes status, MDA, IL-6 and CRP levels were estimated by using standard methods in 40 healthy individuals (control group) and in 40 osteoarthritic patients aged 50–70 years before and after 3 months of vitamin E supplementation, i.e. group I (nonsupplemented) and group II (200 mg/day vitamin E supplemented). The obtained values were compared statistically by using Student’s t-test. Results: Marked alteration in antioxidant enzymes, MDA and inflammatory markers were observed in group I (p < 0.05) as compared with controls. These levels were ameliorated significantly after vitamin E supplementation (p < 0.05) in group II. However, elevated levels of serum CRP and synovial fluid IL-6 (r = 0.034; p < 0.05) were decreased insignificantly (p < 0.1) after vitamin E supplementation in knee OA patients. Conclusions: These findings confirm the protective role of vitamin E supplementation against oxidative stress mediated biomolecular deterioration in OA. However, the anti-inflammatory role of vitamin E remains to be explored.

1 January 2016 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
RSRahul Saxena
Rahul Saxena
Despite, various preventive efforts on conventional cardiovascular disease (CVD) risk factors, the incidence of CVD in rheumatoid arthritis (RA) patients increases continuously. To solve this conundrum one needs more investigations. The present study was conducted to evaluate the plasma paraoxonase (PON) activity along with the markers of systemic inflammation, oxidative stress and disease activity score-28 (DAS28) in RA patients and clarify their role in determining the probability of RA patients to develop future CVD risk. Plasma PON, total antioxidant activity (TAA), C-reactive protein (CRP), synovial interleukin-6 (IL-6) and erythrocyte malondialdehyde (MDA) levels were estimated in 40 RA patients aged 40-55 years aged and 40 age-matched healthy controls. The data obtained were compared statistically by using Student's t-test and Pearson correlation test. Besides dyslipidaemia, marked reduction in plasma PON and TAA (p< 0.05) were observed in RA patients as compared with that of healthy controls. Erythrocyte MDA, plasma CRP and synovial IL-6 levels were increased significantly (p<0.05) in RA patients. PON was negatively correlated with MDA (r = - 0.672; p < 0.001), CRP (r = -0.458; p<0.05), IL-6 (r = -0.426; p<0.05) and DAS28 (r = -0.598; p < 0.001), and positively correlated with HDL cholesterol (r = 0.648; p<0.001) and TAA (r = 0.608; p< 0.001) levels in RA patients. Alteration in PON activity might contribute to the progression of future CVD risk in RA patients, which may result from interplay of several confounding factors, such as inflammation, oxidative stress and dyslipidaemia. Furthermore, plasma PON activity, CRP and TAA levels could be considered as non-traditional factors to predict CVD risk. Thus, it is suggested that future drugs could be developed to target the non-traditional risk factors in RA patients.

1 December 2015 in International Journal of Research in Orthopaedics
Verified
Journal Article
Open access
PDF file
RSRahul Saxena
Rahul Saxena
SSShilpa Suneja
Shilpa Suneja
DSDilutpal Sharma
Dilutpal Sharma
ALAlok Milton Lal
Alok Milton Lal
Background: Oxidative stress has been implicated in the pathophysiology of a number of diseases such as cancer, hypertension and inflammatory diseases. Although previous evidences provided extensive literature about the biological role of antioxidant enzymes in rheumatoid arthritis (RA), there is a paucity of satisfactory explanation regarding the alteration in the level of antioxidant enzymes along with marker of systemic inflammation in RA. The objective of present study was to estimate the level of C-reactive protein (CRP), Superoxide dismutase (SOD), Catalase (CAT), Glutathione peroxidase (GSHPx) and Ceruloplasmin in active RA patients.Methods: 40 patients of either sex (30-50 years age group) suffering from active RA and 40 normal healthy individuals served as control; were included in the study. Above mentioned parameters were estimated using standard methods and data from patients and controls were compared by using Student’s t-test.Results: Erythrocyte SOD, CAT and GSHPx activity were significantly low in RA subjects (P<0.001) whereas plasma Ceruloplasmin level was found to be significantly high (P<0.001) as compared to healthy controls.Conclusions: These findings suggest that combined effect of inflammation and free radical generation is involved in the pathogenesis of active RA, characterized by imbalance in antioxidant enzyme status and enhanced CRP levels, which served as an excellent marker of oxidative stress and systemic inflammation in active RA.

15 March 2015 in Asian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
JDJusmita Dutta
Jusmita Dutta
DSDilutpal Sharma
Dilutpal Sharma
RSRahul Saxena
Rahul Saxena
Background: Osteoarthritis (OA), also known as degenerative arthritis, is the leading cause of chronic disability in elderly. Although, it is a process of progressive deterioration of articular cartilage with ageing which involves numerous risk factors, it is conceivable that oxidative stress mediated electrolyte imbalance may have a crucial role in the development of hypertension risk in OA elderly. Aims & objective: The present study was designed to assess the association of oxidative stress and altered serum electrolyte levels in OA elderly patients and to determine their effect in predicting hypertension (HT) risk. Methods: Total antioxidant activity (TAA), lipid peroxidation (malondialdehyde; MDA) and serum mineral (Na+, K+, Mg2+ and Ca2+) levels were estimated in 40 OA elderly patients by using standard methods and statistically compared it with that of 40 healthy normal individuals of same age group (55-70 years). Result: Plasma TAA, serum potassium, magnesium and calcium levels were significantly low in patient group (p<0.05) as compared to healthy controls whereas erythrocyte MDA levels were significantly high in OA subjects. However, serum sodium levels were increased insignificantly (p<0.1) in OA subjects. Conclusion: Our findings indicate that oxidative stress plays a significant role in shaping the OA older population to develop future hypertension, characterized by altered serum minerals levels. Therefore, consumption of diet rich in antioxidants, proteins and minerals with low dietary salt should be increased with senescence in order to prevent disease complexity.DOI: http://dx.doi.org/10.3126/ajms.v6i5.12274 Asian Journal of Medical Sciences Vol.6(5) 2015 26-30

31 August 2024 in Journal of Lifestyle Medicine
Verified
Journal Article
Open access
PDF file
NPNawaj Pathan
Nawaj Pathan
RSRahul Saxena
Rahul Saxena
Chandan KumarChandan Kumar
Chandan Kumar
SKSampada Kamlakar
Sampada Kamlakar
AYAnkita Yelikar
Ankita Yelikar
Nawaj Mehtab Pathan, Rahul Saxena, Chandan Kumar, Sampada Kamlakar, Ankita Yelikar. JLM 2024;14:94-7. https://doi.org/10.15280/jlm.2024.14.2.94

25 December 2015 in International Journal of Research in Dermatology
Verified
Journal Article
Open access
PDF file
RSRahul Saxena
Rahul Saxena
SSShilpa Suneja
Shilpa Suneja
RSRaj Saxena
Raj Saxena
DSDilutpal Sharma
Dilutpal Sharma
ALAlok Milton Lal
Alok Milton Lal
Background: Psoriasis is characterized by systemic increase of inflammation and oxidative stress. In addition, increased incidence of dyslipidemia in dermatological disorders is also in alarming phase. It is conceivable that association of inflammation, oxidative stress and dyslipidemia enhances the future the risk of cardiovascular disease (CVD) in psoriasis patients. The main of the study is to estimate the marker of systemic inflammation, oxidative stress, plasma lipid profile and apolipoprotein levels in psoriasis patients and to determine their role in predicting CVD risk in psoriasis. Methods: The study population consist of subjects categorized into two groups; Group I: Healthy controls and Group II: Psoriasis patients (n= 25 in each group). Erythrocyte malondialdehyde (MDA), plasma C-reactive protein (CRP) and lipid profile along with apolipoprotein B and A1 were measured and statistically analyzed using standard methods. Results: Plasma CRP, total cholesterol, triglycerides, LDL-cholesterol and MDA levels were significantly high (p<0.05) in patient group as compared to healthy controls. HDL-cholesterol levels were altered insignificantly (p<0.1) in patient group. Plasma Apo B/Apo A1 ratio were increased significantly (p<0.01) in patient groups as compared to controls. Conclusions: Thus, enhanced inflammation, oxidative stress along with increase in Apo B, A1 and its ratio authenticates the fact that these markers are more efficient in prediction of CVD risk in psoriasis patients than conventional lipid profile parameters.